Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bloch

Showing results (531-540 of 559) with videos related to

Pageof 56
Sort By:
Annals of Internal Medicine|May 12, 2025
Medical, Societal, and Ethical Considerations for Directed Blood Donation in 2025Jeremy W Jacobs, Garrett S Booth, Mithya Lewis-Newby, et al.
Lancet Regional Health. Americas|May 15, 2024
Factitious disorder presenting as sickle cell disease: a case reportJeremy W Jacobs, Juliana Guarente, Julie K Karp, et al.
Medrxiv : the Preprint Server for Health Sciences|March 9, 2022
High Viral Specific Antibody Convalescent Plasma Effectively Neutralizes SARS-CoV-2 Variants of ConcernMaggie Li, Evan J Beck, Oliver Laeyendecker, et al.
Physical Review Letters|February 6, 2025
First Direct-Detection Results on Sub-GeV Dark Matter Using the SENSEI Detector at SNOLABPrakruth Adari, Itay M Bloch, Ana M Botti, et al.
Transfusion|March 30, 2022
How do I implement an outpatient program for the administration of convalescent plasma for COVID-19?Evan M Bloch, Aaron A R Tobian, Shmuel Shoham, et al.
Transfusion|May 31, 2023
SARS-CoV-2 seroprevalence among blood donors in Uganda: 2019-2022Evan M Bloch, Dorothy Kyeyune, Jodie L White, et al.
Blood Advances|April 20, 2022
Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concernMaggie Li, Evan J Beck, Oliver Laeyendecker, et al.
JCI Insight|February 1, 2022
Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infectionHan-Sol Park, Janna R Shapiro, Ioannis Sitaras, et al.
Journal of Clinical Apheresis|March 27, 2025
A Descriptive 5-Year Analysis of the Demographics and Therapies for Patients With Immune Thrombotic Thrombocytopenic Purpura in the USA: A Multicenter Study of 390 Disease Episodes From 2017 to 2021Jeremy W Jacobs, Brian D Adkins, Garrett S Booth, et al.
Plos One|June 27, 2019
Pharmacogenomics of statin-related myopathy: Meta-analysis of rare variants from whole-exome sequencingJames S Floyd, Katarzyna M Bloch, Jennifer A Brody, et al.
Pageof 56

Showing results (531-540 of 559) with videos related to

Sort By:
Pageof 56
Annals of Internal Medicine|May 12, 2025
Medical, Societal, and Ethical Considerations for Directed Blood Donation in 2025Jeremy W Jacobs, Garrett S Booth, Mithya Lewis-Newby, et al.
Lancet Regional Health. Americas|May 15, 2024
Factitious disorder presenting as sickle cell disease: a case reportJeremy W Jacobs, Juliana Guarente, Julie K Karp, et al.
Medrxiv : the Preprint Server for Health Sciences|March 9, 2022
High Viral Specific Antibody Convalescent Plasma Effectively Neutralizes SARS-CoV-2 Variants of ConcernMaggie Li, Evan J Beck, Oliver Laeyendecker, et al.
Physical Review Letters|February 6, 2025
First Direct-Detection Results on Sub-GeV Dark Matter Using the SENSEI Detector at SNOLABPrakruth Adari, Itay M Bloch, Ana M Botti, et al.
Transfusion|March 30, 2022
How do I implement an outpatient program for the administration of convalescent plasma for COVID-19?Evan M Bloch, Aaron A R Tobian, Shmuel Shoham, et al.
Transfusion|May 31, 2023
SARS-CoV-2 seroprevalence among blood donors in Uganda: 2019-2022Evan M Bloch, Dorothy Kyeyune, Jodie L White, et al.
Blood Advances|April 20, 2022
Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concernMaggie Li, Evan J Beck, Oliver Laeyendecker, et al.
JCI Insight|February 1, 2022
Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infectionHan-Sol Park, Janna R Shapiro, Ioannis Sitaras, et al.
Journal of Clinical Apheresis|March 27, 2025
A Descriptive 5-Year Analysis of the Demographics and Therapies for Patients With Immune Thrombotic Thrombocytopenic Purpura in the USA: A Multicenter Study of 390 Disease Episodes From 2017 to 2021Jeremy W Jacobs, Brian D Adkins, Garrett S Booth, et al.
Plos One|June 27, 2019
Pharmacogenomics of statin-related myopathy: Meta-analysis of rare variants from whole-exome sequencingJames S Floyd, Katarzyna M Bloch, Jennifer A Brody, et al.
Pageof 56